Corient Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$216K Hold
2,707
0.02% 592
2022
Q2
$216K Sell
2,707
-400
-13% -$31.9K 0.02% 606
2022
Q1
$327K Buy
3,107
+33
+1% +$3.47K 0.02% 509
2021
Q4
$331K Buy
3,074
+87
+3% +$9.37K 0.02% 482
2021
Q3
$327K Buy
2,987
+345
+13% +$37.8K 0.02% 468
2021
Q2
$247K Buy
2,642
+469
+22% +$43.8K 0.02% 555
2021
Q1
$200K Buy
+2,173
New +$200K 0.02% 572